Moody’s affirms ‘A1’ rating on Vidant Health

Moody’s Investors Service affirmed its “A1” rating on Greenville, N.C.-based Vidant Health’s bonds, affecting $430 million of debt.

Advertisement

The affirmation is a result of several factors, including the health system’s strong market share, large size, profitable margins and stable balance sheet. Moody’s unfavorably viewed the health system’s high debt burden, unfavorable payer mix and low population growth.

The outlook is stable, reflecting Moody’s expectation that Vidant Health will maintain its profitable financial performance despite the headwinds.

More articles on healthcare finance:
Hospital uncompensated care surges 14% to $1.1B in Wisconsin
Mayo Clinic gets $10M donation to support 5 initiatives
12 recent hospital, health system outlook and credit rating actions

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.